Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 684 of 1,261

  1. US 9394303

    Small molecule inhibitors of MCL-1 and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  2. US 9394316

    Inhibitors of the plasmodial surface anion channel as antimalarials

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  3. US 9394338

    Glutathione analogs and uses thereof

    Regents of the University of Minnesota · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  4. US 9394234

    Lipid formulations

    ARBUTUS BIOPHARMA CORPORATION · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  5. US 9394281

    Substituted heteroaryl compounds and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  6. US 9394241

    Composition and method for making oligo-benzamide compounds

    The Board of Regents of the University of Texas System · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  7. US 9393271

    GHRH agonists for islet cell transplantation and function and the treatment of diabetes

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  8. US 9393306

    Singlet oxygen-labile linkers and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  9. US 9393305

    Etanercept formulations stabilized with xylitol

    Coherus BioSciences, Inc. · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  10. US 9393285

    Compositions for treating dry eye disease

    The Regents of the University of California · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  11. US 9393257

    TALEN-based gene correction

    Regents of the University of Minnesota · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  12. US 9394343

    Appetite stimulating protein

    The Regents of the University of California · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  13. US 9393235

    Pyridone amides as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  14. US 9387205

    Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

    TAKEDA GMBH · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  15. US 9388247

    Antibodies against cancer target block tumor growth, angiogenesis and metastatis

    The Regents of the University of California · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  16. US 9387220

    Method for inducing hepatocyte proliferation and uses thereof

    CAN-FITE BIOPHARMA LTD. · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  17. US 9387217

    Acyclic nucleoside phosphonate diesters

    The Regents of the University of California · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  18. US 9387214

    Method of identifying therapies for pulmonary hypertension

    United Therapeutics Corporation · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  19. US 9388244

    Internalizing ErbB2 antibodies

    The Regents of the University of California · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  20. US 9388408

    Oligonucleotide-based inhibitors comprising locked nucleic acid motif

    MIRAGEN THERAPEUTICS, INC. · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  21. US 9388189

    Pyrrolotriazinone derivatives as PI3K inhibitors

    Almirall, S.A. · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  22. US 9388221

    Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  23. US 9388218

    PRRSV compositions

    Regents of the University of Minnesota · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  24. US 9388164

    Methods of using pyruvate kinase activators

    Agios Pharmaceuticals, Inc. · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.